Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

CoreLogic Q4 Net Loss Narrows; Reconfirms FY12 Guidance - Quick Facts

RELATED NEWS
Trade CLGX now with 

CoreLogic, Inc. (CLGX: Quote) reported that its fourth-quarter net loss attributable to the company narrowed to $14.14 million or $0.13 per share, from $27.74 million or $0.24 per share in the same quarter last year.

Operating revenue for the quarter rose to $345.40 million from $315.37 million in the prior year quarter. Analysts polled by Thomson Reuters expected the company to report revenues of $330.68 million for the quarter. Analysts' estimates typically exclude special items.

The company reconfirmed its guidance for 2012. The company still expects adjusted earnings in a range of $0.95 to $1.05 and adjusted revenue of $1.425 billion to $1.475 billion for fiscal year 2012. Analysts expect the company to report earnings of $0.95 per share on revenues of $1.47 billion for fiscal 2012.

Click here to receive FREE breaking news email alerts for CoreLogic Inc. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Swiss drug maker Roche Holding said a late-stage trial of its breast cancer drug Kadcyla did not provide superior results compared with an existing therapy. FCA US, until recently known as Chrysler, said Friday it is recalling 257,000 Dodge Ram pickups. The auto maker says the rear axle pinion nut on certain model year 2005 Dodge Ram 1500 trucks may loosen due to an undersized spline on the pinion gear. If the pinion nut loosens, the rear axle may... This medical device company has a very impressive track record of growing business over the past decade. increasing sales from $490.2 million in 2004 to $1.72 billion this year. The Silicone Hydrogel daily disposable lens portfolio constitutes a major avenue for growth.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.